Keynote lectures

CEA or CAS for asymptomatic carotid stenosis – which patients benefit most?

Alison Halliday, Oxford, UK

Thursday, 06 December 2018 | 09.00-10.35 | CAD 1 | Lecture Hall B

Alison Halliday is Professor of Vascular Surgery and Honorary Consultant Vascular Surgeon, Oxford University Hospitals. She is Lead Researcher in the ACST Trials and is the recent ESVS President. Her work has contributed to NICE and to the National and International Stroke Guidelines. She has contributed to the ESVS European Guidelines Committee for Extracranial Vascular Disease and is the member of the European Society for Cardiology, Council on Stroke.


Transcarotid stenting (T-CAR) vs. CEA and transfemoral CAS in the SVS Vascular Quality Initiative

Marc Schermerhorn, Boston, USA

Thursday, 06 December 2018 | 11.00-12.25 | CAD 2 | Lecture Hall B

Marc Schermerhorn, M.D., is Chief of the Division of Vascular and Endovascular Surgery at Beth Israel Deaconess Medical Center and the George H. A. Clowes Jr. Professor of Surgery at Harvard Medical School. He is Treasurer of the New England Society for Vascular Surgery and a Distinguished Fellow of the Society for Vascular Surgery. He is a member of the European Society for Vascular Surgery, American College of Surgeons, and American Heart Association and serves as a member of the Medical Devices Advisory Panel for the FDA and consultant for the Agency for Healthcare Research and Quality. He is a member of three editorial boards and a reviewer for 13 other major journals. In addition, he is an international leader in the field of clinical effectiveness research with a particular focus on the impact of new endovascular therapies on aortic aneurysm repair. He has an NIH funded lab and has authored more than 250 peer-reviewed articles, case reports, book chapters, and reviews, including original manuscripts in the New England Journal of Medicine, and the Journal of the American Medical Association and has lectured at many national and international forums. He is mentor to numerous surgical residents interested in pursuing careers as clinical investigators.


Immediate, intermediate, and long-term results after CEA and CAS in four RCTs on symptomatic carotid stenosis

Leo Bonati, Basle, Switzerland

Thursday, 06 December 2018 | 13.30-14.55 | CAD 3 | Lecture Hall B

Professor Leo Bonati is a Neurologist working in the Department of Neurology at the University Hospital Basel in Switzerland. He is the Head of the Acute Stroke Unit and the Neurovascular Outpatient Clinic of the local Stroke Center. Prof Bonati obtained his MD, Venia Docendi (Habilitation), and Professor of Neurology at the University of Basel. He trained as a clinical Neurologist and clinical researcher in Basel, and spent a two-year Research Fellowship at the University College London’s Institute of Neurology (Queen Square), under the supervision of Prof. Martin M. Brown.
Prof Bonati’s main research focus is on carotid artery disease. He led the final analysis of the pivotal International Carotid Stenting Study (ICSS), the largest RCT comparing carotid endarterectomy versus stenting in patients with symptomatic carotid stenosis. A particular focus of Prof Bonati’s research in the field of carotid disease has been the use of magnetic resonance imaging (MRI) for outcome assessment in carotid intervention trials. Prof. Bonati is the Coordinator of the Carotid Stenosis Trialists Collaboration (CSTC), a collaboration between four leading international research groups in the field of carotid disease with the aim of performing pooled analyses of RCT data to select the best treatment for individual patients. He is also a member of the Steering Committee of the 2nd European Carotid Surgery Trial (ECST-2) comparing invasive revascularisation versus best medical therapy alone in patients with low-to-intermediate risk carotid disease; neurological Co-Principal Investigator of the 2nd Asymptomatic Carotid Surgery Trial (ACST-2) comparing endarterectomy versus stenting for asymptomatic carotid stenosis; and Principal Investigator of the PRECISE-MRI trial comparing ticagrelor versus clopidogrel in patients undergoing carotid artery stenting.
Prof Bonati is the Coordinator of the Swiss Stroke Registry, a standardised web-accessible database capturing event-related and follow-up data of all patients with acute cerebrovascular events admitted to certified primary and comprehensive Stroke Centers in Switzerland. Further research areas of Prof Bonati include diagnosis and treatment of acute stroke, biomarkers, and atrial fibrillation.


Civilian and pediatric vascular trauma management – an overview

Rolf Kolvenbach, Düsseldorf, Germany

Thursday, 06 December 2018 | 17.25-18.30 | PAD 2 | Lecture Hall B

  • Director Department of Vascular Surgery and Endovascular Therapy, Augusta Hospital and Catholic Clinics Group Duesseldorf. Teaching Hospital University of Duesseldorf
  • Lecturer and Attending Surgeon Hadassah Medical Centre, University of Jerusalem Israel
  • Medical Director Vascular Outpatient Clinic (CAT GmbH) Duesseldorf
  • Clinical (apl.) Professor of Vascular Surgery, Heinrich – Heine University of Duesseldorf
  • Professor Fliedner University Duesseldorf
  • Honorary Professor Sino-Japanese Friendship Hospital, University of Beijing, China, Staff Member Department of Cardiovascular Surgery


Carotid plaque burden predicts future cardiovascular events – why and how I do it!

David Spence, London, Canada

Friday, 07 December 2018 | 10.30-11.40 | CAD 6 | Lecture Hall C

Professor Spence trained in Neurology and Internal Medicine at Western University in London, Canada, then did a fellowship in Clinical Pharmacology at the Cardiovascular Research Institute, University of California at San Francisco. He has spent his entire career in stroke prevention. After running a hypertension clinic for 20 years he pioneered measurement of carotid plaque burden for risk stratification, genetic research, management of patients and evaluation of new therapies for atherosclerosis. His other areas of expertise include B vitamins to lower homocysteine, physiologically individualized therapy for resistant hypertension, transcranial Doppler for risk stratification in asymptomatic carotid stenosis and patent foramen ovale, and more recently, effects of the intestinal microbiome on atherosclerosis. He has seen over 40,000 patients at high risk of stroke, thereby preventing some 10,000 strokes. However, through his more than 400 publications and more than 600 lectures on stroke prevention to tens of thousands of physicians in 38 countries, he has accomplished much more for stroke prevention than he could achieve as an individual physician.
In 2015 he received the Research Excellence Award from the Canadian Society for Atherosclerosis, Thrombosis and Vascular Biology, and in 2017 he was named a Distinguished Alumnus of Western University for Professional Achievement.


The new ESVS guidelines – what is new and what is different from the 2017 SVS AAA guidelines?

Anders Wanhainen, Uppsala, Sweden

Friday, 07 December 2018 | 08.30-10.05 | AOR 4 | Lecture Hall B 

Anders Wanhainen, MD, PhD, is Professor of Surgery and head of the Vascular Surgical Research Group at Uppsala University, and clinical Chief of the Department of Vascular Surgery, Uppsala University Hospital, Uppsala, Sweden.
Professor Wanhainen is a general and vascular surgeon who specializes in advanced open and endovascular surgery of complex aortic aneurysms and dissections. He has served as president of the Swedish Society for Vascular Surgery and council member of the European Society for Vascular Surgery.
Professor Wanhainen’s research interests include epidemiological and clinical aspects of aortic diseases, with special focus on pathophysiology, screening, surgical/endovascular repair, and medical treatment. Other areas of interest are vascular infections, carotid disease, extremity ischemia, radiation and abdominal compartment syndrome. He has authored more than 200 articles in peer-reviewed medical journals and textbooks, and chaired the new ESVS aortic guideline writing committee. He is the supervisor for 29 PhD-students; eleven who completed their PhD. Professor Wanhainen has been PI for several clinical research projects and receives research grants from the Swedish Research Council and the Swedish Heart and Lung Foundation.
He was awarded The Linné Foundation Medical Research Award 2007, The Swedish Surgical Society’s “Great Surgical Research Prize” in 2011, the Swedish Vascular Award 2008 and 2014.
Uppsala University, founded in 1477, is the oldest university in Scandinavia. Among the University’s alumni there are 15 Nobel Prize laureates. Uppsala University Hospital has an uptake of approximately 3 million people for highly specialized vascular surgery, training and research.

Technological advances in the endovascular treatment of calcified peripheral lesions?

Thomas Zeller, Bad Krozingen, Germany

Friday, 07 December 2018 | 12.45-14.30 | PAD 3 | Lecture Hall C

09.08.1994 | Admission Medical Specialist Internal Medicine
10.10.1995 |  Subarea Term Cardiology
12.01.1996 | Subarea Term Angiology
23.02.2006 | Admission “Hypertension Specialist” by the German Hypertension League (DHL)

Honors and Awards
2001 | Young Investigator Award, International College of Angiology
2013 | Honorary Membership at the Austrian Society of Angiology
2014 | Life Time Carreer Achievement Award, C3 congress
2015 | President elect of the Annual Meeting of the German Society of Angiology
2017 | Leader In EndoVascular Education (LIVE) Award, VIVA Group

Scientific Activity

  • Member “Guideline Commission” European Society of Cardiology 2012
  • Current or past: Member of Scientific Committee of „Transcatheter Therapeutics (TCT) Congress”, Euro-PCR, “Leipzig Interventional Course” (LINC), “Resistant Hypertension Course” (RHC), “Complex Cardiovascular Catheter Therapeutics” (C3); Board of Directors Charing Cross Meeting 2019, Co-Chairman of the Amputation Prevention Meeting (AMP), Complex Cardiovascular Catheter Therapeutics (C3) Meeting, Nationaler Interdisziplinärer Kongress zur kritischen Extremitätenischämie
  • Current or in the past: Editorial Board Member of the medical journals VASA, EUROIntervention , Vascular Medicine, Catheterization Cardiovascular Interventions, Journal of Endovascular Therapy, Cardiovascular and Interventional Radiology
  • Author of more than 250 peer reviewed original and review articles, editor of the textbook Vascular Medicine – Therapy and Practice


Why the current international guidelines are not always accurate to define the best technique for varicose veins

Armando Mansilha, Porto, Portugal

Saturday, 08 December 2018 | 13.30-14.45 | VEN 4 | Lecture Hall B

2001 | Specialist in Angiology and Vascular Surgery, Portuguese Medical Association
2002 | Fellow of the European Board of Vascular Surgery, UEMS
2005 | PhD in Angiology and Vascular Surgery, Faculty of Medicine of  University of Porto

Academic and Hospital appointments (selected)
2005 | Professor of Angiology and Vascular Surgery, Faculty of Medicine of University of Porto
2010 | Director, Department of Angiology and Vascular Surgery, Hospital CUF Porto

Positions (selected)
2005 | Council Member, Union International de Phlébologie
2006 | Executive Committee, College of Angiology and Vascular Surgery, Portuguese

Medical Association
2008 | Secretary General, Portuguese Society of Angiology and Vascular Surgery
2009 | Secretary General, UEMS Section and Board of Vascular Surgery
2009 | Council Member, European Society for Vascular Surgery
2013 | Council Member, Mediterranean League of Angiology and Vascular Surgery
2013 | Honorary Member, The Vascular Society for Great Britain and Ireland
2014 | Council Member, International Union of Angiology
2015 | President of the LOC Annual Meeting, European Society for Vascular Surgery
2016 | President, European Venous Forum
2017 | Moynihan Club Member
2017 | Honorary Member, Societat Catalana d’Angiologia, Cirurgia Vascular I Endovascular
2018 | President, Portuguese Society of Angiology and Vascular Surgery